PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Sep-2024 MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year MeVis Medical Solutions AG
04-Sep-2024 Tenon Medical Announces 1:8 Reverse Split AccessWire
04-Sep-2024 WHO’s mpox response plan provides direction for coordinated response to reduce disease burden, says GlobalData World Health Organization (WHO)
04-Sep-2024 Adults in England and Wales with rare blood disorder to get access to new oral monotherapy on NHS Novartis
04-Sep-2024 Vesper Bio announces successful Phase I study for potentially disease-modifying treatment for frontotemporal dementia Vesper Bio
04-Sep-2024 Phesi wins Frost & Sullivan’s Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with its Trial Accelerator Platform Phesi
04-Sep-2024 Kosten Digital Launches in the U.S. to Transform Life Sciences with Custom AI Solutions, Welcomes Industry Leader Amy DuRoss to Advisory Board Kosten Digital
04-Sep-2024 Russell Abberley, Amgen UK & Ireland, steps up as Acting ABPI President Association of the British Pharmaceutical Industry (ABPI)
04-Sep-2024 MHRA licenses first in new class of treatment for patients with endometriosis symptoms in the UK Gedeon Richter UK Ltd
04-Sep-2024 Envirotainer completes integration of va-Q-tec’s pharma business, advancing the future of pharma cold chain Envirotainer
04-Sep-2024 Vesper Bio announces successful Phase I study for potentially disease-modifying treatment for frontotemporal dementia Vesper Bio
04-Sep-2024 PulseSight Therapeutics reinforces its scientific leadership in ophthalmology with the establishment of an International Scientific and Clinical Advisory Board PulseSight Therapeutics SAS
04-Sep-2024 Actimed Therapeutics Announces US FDA Grant of Orphan Drug Designation to S-oxprenolol (ACM-002) for the Treatment of Amyotrophic Lateral Sclerosis (ALS) Actimed Therapeutics
04-Sep-2024 Aixial Group Migrates Specific Clinical Data Portfolio Onto Medidata Platform to Create a Single Source of Truth and Accelerate Database Lock Medidata
04-Sep-2024 Prilenia’s Pridopidine for Huntington’s Disease Accepted for European Marketing Authorisation Review Prilenia Therapeutics B.V
04-Sep-2024 NH TherAguix announces continuation of the Phase II NANOBRAINMETS trial in the treatment of brain metastases after completion of a futility analysis NH TherAguix (NHT)
04-Sep-2024 GenesisCare UK appoints Second Doctor Director to UK Board GenesisCare UK
04-Sep-2024 New application addresses scientific replication crisis DeSci Labs
04-Sep-2024 Amferia closes €1,2 million investment to combat resistant bacterial infections Amferia
04-Sep-2024 QL Biopharm Announces Abstract on Novel Ultra Long-acting GLP-1RA to be Presented at EASD Annual Meeting 2024 QL Biopharm